Troluce Capital Advisors LLC

Position in ABVX — Abivax S.A.

CIK 1910321 DORADO, PR

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$133,260

New position

Shares Held

1,000

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#244

of 301 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Troluce Capital Advisors LLC holds $63,017,746 across 3 Biotechnology names. ABVX ranks #3 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,728,753	$46,641,755
2	STOK	Stoke Therapeutics, Inc.	496,416	$16,242,731
3	ABVX	Abivax S.A. This page	1,000	$133,260

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$133,260	1,000	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.